Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective

Aspirin and Cancer

(2016) Paola Patrignani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study

(2016) Sadanori Okada et al.   PLoS One

Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk

(2015) Melania Dovizio et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Cyclooxygenase inhibitors: From pharmacology to clinical read-outs

(2015) Paola Patrignani et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes

(2015) Francesco Zaccardi et al.   DIABETES

Nonsteroidal Anti-Inflammatory Drugs and the Heart

(2014) Carlo Patrono et al.   CIRCULATION

Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs

(2014) Xuanwen Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia

(2014) Isabella Squellerio et al.   THROMBOSIS AND HAEMOSTASIS

Platelet activation and inhibition in polycythemia vera and essential thrombocythemia

(2013) C. Patrono et al.   BLOOD

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

(2013)   LANCET

COX-2, the dominant source of prostacyclin

(2013) E. Ricciotti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects

(2012) Emma J. Turtle et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cell Selective Cardiovascular Biology of Microsomal Prostaglandin E Synthase-1

(2012) Lihong Chen et al.   CIRCULATION

Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system

(2012) N. S. Kirkby et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice

(2012) Y. Yu et al.   Science Translational Medicine

Prostaglandins and Inflammation

(2011) Emanuela Ricciotti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

(2009) Matthew C. Becker et al.   AMERICAN HEART JOURNAL

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

(2009) A. Dragani et al.   BLOOD

Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays

(2009) Francesca Santilli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function

(2009) D. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population

(2008) Luis Alberto García Rodríguez et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial

(2008) John A Baron et al.   LANCET